Preimplantation Genetic Testing Market Research Report, Trends, Demand, Key Players Analysis and Forecast 2023-2028

IMARC Group's latest research report, titled "Preimplantation Genetic Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the global preimplantation genetic testing market size reached US$ 527 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 883 Million by 2028, exhibiting a growth rate (CAGR) of 9.1% during 2023-2028.

Preimplantation Genetic Testing (PGT) is a reproductive technology used during the in vitro fertilization (IVF) process to screen embryos for genetic abnormalities before implantation. It involves the removal of one or more cells from the embryo, which are then analyzed for chromosomal abnormalities or specific genetic disorders.

It helps identify embryos with a higher chance of successful pregnancy and lowers the risk of passing on inherited genetic diseases to offspring. It provides valuable information to prospective parents, enabling them to make informed decisions regarding embryo selection and family planning. It has revolutionized assisted reproductive techniques, offering hope to couples struggling with infertility or genetic concerns and improving the chances of a healthy pregnancy and the birth of a healthy child.

Get Sample Copy of Report at - https://www.imarcgroup.com/preimplantation-genetic-testing-market/requestsample

Market Growth and Demand:

The global market is majorly driven by the increasing incidence of genetic disorders, such as chromosomal abnormalities and single-gene disorders. In line with this, rapid technological advancements are improving the accuracy, speed, and efficiency of PGT, making it more accessible and reliable for couples undergoing assisted reproductive procedures. Furthermore, the rising awareness regarding the benefits of PGT, including the ability to prevent the transmission of genetic diseases, has led to greater acceptance and demand for these services among couples seeking to have children. Apart from this, the growing prevalence of infertility issues is resulting in an accelerating demand for assisted reproductive techniques, including IVF with PGT, to enhance the chances of successful pregnancy and healthy offspring. With more couples choosing to delay parenthood due to career aspirations or other personal factors, there is an escalating need for PGT to mitigate the potential risks associated with advanced maternal age.

Moreover, favorable regulations and guidelines from healthcare authorities, ensuring the safety and efficacy of PGT, have contributed to market growth by instilling confidence in patients and healthcare providers. Besides, the growth of the middle class and rising disposable incomes have made PGT more accessible to a larger population, thereby expanding the market. Additionally, advances in IVF techniques, combined with PGT, have improved success rates in achieving a viable pregnancy, encouraging more couples to opt for these procedures.

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/preimplantation-genetic-testing-market

Key Players of the Market:

• Abbott Laboratories
• Agilent Technologies Inc
• F. Hoffmann-La Roche Ltd
• Illumina Inc
• Laboratory Corporation of America Holdings
• Natera Inc
• Oxford Gene Technology IP Limited (Sysmex Corporation)
• PerkinElmer Inc
• Quest Diagnostics Incorporated,
• The Cooper Companies Inc
• Thermo Fisher Scientific

Key Market Segmentation:

Breakup by Product:

• Reagents and Consumables
• Instruments

Breakup by Procedure:

• Preimplantation Genetic Screening
• Preimplantation Genetic Diagnosis

Breakup by Technology:

• Next-Generation Sequencing
• Polymerase Chain Reaction
• Fluorescence in Situ Hybridization
• Comparative Genomic Hybridization
• Single-Nucleotide Polymorphism

Breakup by Application:

• Aneuploidy
• Single Gene Disorder
• Structural Chromosomal Abnormalities
o Translocations
o Deletions
o Duplications
o Inversions
• X-Linked Disorders
• Human Leukocyte Typing
• Gender Identification

Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:
• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Who we are:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.